Two types of laser treatment for trigeminal neuralgia pain compared
Compares two laser treatments for facial nerve pain in adults with trigeminal neuralgia.
Key facts
- Who runs it
- Alexandria University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- High-intensity Laser Therapy Versus Low Level Laser Therapy in the Treatment of Trigeminal Neuralgia
- Status
- Not yet recruiting
- People taking part
- 38 people, planned
- Started
- 15 May 2026
- Expected to end
- 30 Dec 2026
- Type of study
- Interventional, 2 groups
- Treatments tested
- 1064 nm Nd-YAG Laser
- 940 nm Diode laser
- Record updated
- 15 May 2026
Who can take part
The trial is looking for adults with trigeminal neuralgia, a severe facial nerve pain, that has not improved with medicines. It compares two types of laser treatment.
- Age
- 18 Years and older
- Sex
- All
- Disease stage
- Trigeminal neuralgia diagnosed by the ICHD-3 criteria. Pain must not respond to medicines (drug refractory).
- Earlier treatment
- Poor response to adequate medicines, or side effects too hard to bear, for at least three months. People must be unable to have surgery or other procedures, or have had them without enough pain relief.
- Main reasons for not taking part
- Trigeminal neuralgia caused by a brain lesion that needs surgery
- Other face or jaw conditions, migraine, or other nerve diseases
- Reasons laser cannot be used, such as a pacemaker
- Responding well to medical treatment
- Pregnant or breastfeeding women
Show the full registry criteria (8)Hide the full registry criteria
Who can take part
- Patients diagnosed with trigeminal neuralgia according to the International Classification of Headache Disorders (ICHD-3) diagnostic criteria
- Patients with drug refractory trigeminal neuralgia (defined as poor response to adequate pharmacological treatment or intolerance to side effects for at least three months)
- Patients who are contraindicated for surgical intervention or any other interventions, or who have previously undergone such interventions without obtaining satisfactory pain relief
Who cannot take part
- patients with secondary trigeminal neuralgia diagnosed with brain lesions that is indicated for surgery (percutaneous procedures, gamma knife, microvascular decompression)
- Patients with other orofacial conditions such as temporomandibular disorders, migraine, or other neurological diseases
- Patients with contraindications to laser use (e.g., pacemakers)
- Patients who are responding well to medical treatment
- Pregnant or lactating women
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Trigeminal neuralgia
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Trigeminal neuralgia (TN) is the most common and severe type of neuropathic pain disorder affecting the orofacial region. It is characterized by sudden, intense, episodic attacks of pain in the distribution of trigeminal nerve, usually unilateral. The condition severely impairs patient's quality of life. TN represents a diagnostic and therapeutic challenge, pharmacological therapy remains the first-line management, and many patients experience reduced drug tolerance or significant side effects over time. Surgical options are considered for refractory cases but are invasive and carry risks such as infection, nerve damage, and recurrence of symptoms. In recent years, laser based therapies have gained attention as safe, non-invasive alternatives. Low level laser therapy (LLLT) promotes photo-biomodulation and nerve repair without thermal damage, while high-intensity laser therapy (HILT) can achieve deeper penetration and direct neuromodulation. However, comparative evidence regarding their efficacy in TN is still limited. Aim: The present study aims to evaluate and compare the effect of High intensity laser therapy and low level laser therapy in reducing pain intensity and improving quality of life in patients with trigeminal neuralgia.
The 2 groups in the trial
- Nd-YAG LaserTreatment being tested
Treatment: 1064 nm Nd-YAG Laser
- Diode laserTreatment being tested
Treatment: 940 nm Diode laser
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- High-intensity Laser Therapy Versus Low Level Laser Therapy in the Treatment of Trigeminal Neuralgia (a Randomized Clinical Trial)
- Plain-language title
- Two types of laser treatment for trigeminal neuralgia pain comparedGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Criteria questions
- Built from NCT07590414, who can take part
- Record updated
- 15 May 2026